Compare HXL & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HXL | BRKR |
|---|---|---|
| Founded | 1946 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.8B | 6.2B |
| IPO Year | 1994 | 2000 |
| Metric | HXL | BRKR |
|---|---|---|
| Price | $92.66 | $43.85 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 13 |
| Target Price | ★ $88.30 | $48.54 |
| AVG Volume (30 Days) | 1.1M | ★ 1.9M |
| Earning Date | 04-22-2026 | 05-06-2026 |
| Dividend Yield | ★ 0.80% | 0.58% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.02 |
| Revenue | $1,893,900,000.00 | ★ $1,895,600,000.00 |
| Revenue This Year | $10.09 | $6.30 |
| Revenue Next Year | $12.33 | $3.81 |
| P/E Ratio | ★ N/A | $2,234.75 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $51.52 | $28.53 |
| 52 Week High | $98.26 | $56.22 |
| Indicator | HXL | BRKR |
|---|---|---|
| Relative Strength Index (RSI) | 55.61 | 64.63 |
| Support Level | $88.83 | $33.09 |
| Resistance Level | $94.18 | $49.44 |
| Average True Range (ATR) | 2.89 | 1.79 |
| MACD | -0.11 | 0.76 |
| Stochastic Oscillator | 53.27 | 87.81 |
Founded in 1948, Hexcel designs and manufactures a range of highly engineered composite fibers, fabrics, resins, and structures for use primarily in the commercial aerospace and defense markets. These are lighter than metal and perform under rigorous conditions in aircraft frames, wings, engine nacelles, and other structures and subassemblies. The company's name derives from the six-sided honeycomb structures that lend many of its products their light weight and rigidity. Hexcel's biggest customers are Airbus (40% of 2024 sales) and Boeing (15% of 2024 sales; 25% before the pandemic) and their respective subcontractors.
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.